Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-11-03–present
Dr. David J. Brailer
Board Member
Teva Pharmaceutical Industries Ltd (TEVA)Equibles does not estimate personal net worth.
Get an email with a short summary when Teva Pharmaceutical Industries Ltd publishes a filing, an earnings call transcript or a press release.
Get TEVA alertsAbout Dr. David J. Brailer
Dr. David J. Brailer is recorded as Board Member at Teva Pharmaceutical Industries Ltd (TEVA) since November 3, 2026. Teva Pharmaceutical Industries Ltd reported in an 8-K filed October 29, 2026 that Dr. David J. Brailer was appointed member of the Board, effective November 3, 2026. Teva Pharmaceutical Industries Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Teva Pharmaceutical Industries Ltd includes Richard Francis (CEO and Board Member), Eli Kalif (CFO), Amir Weiss (Chief Accounting Officer) and 6 others.
“On October 27, 2026, at a meeting of the Board of Directors (the “Board”) of Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”), the Board elected Dr. David J. Brailer to serve as a member of the Board, effective November 3, 2026, until Teva’s 2027 annual meeting of shareholders.”
Affiliation history
-
Current
2026-11-03–present
Company network
Leadership on record at Teva Pharmaceutical Industries Ltd
- Richard Francis CEO, Board Member
- Eli Kalif CFO
- Amir Weiss Chief Accounting Officer
- Andrew Weil Chief Accounting Officer
- Abbas Hussain Board Member
- Chen Lichtenstein Board Member
- Dr. Sol J. Barer Board Member
- Nechemia (Chemi) J. Peres Board Member
- Prof. Varda Shalev Board Member